Chemotherapy-induced oral mucositis: Prevention and management

Drugs and Aging

Volumn 17, Issue 4, 2000, Pages 257-267

  Knox, Jennifer J ^a   Puodziunas, Anitasha L V ^a   Feld, Ronald ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLOPURINOL; ANTINEOPLASTIC AGENT; BETA CAROTENE; CHAMOMILE; CHLORHEXIDINE; FLUOROURACIL; FOLINIC ACID; GLUCOCORTICOID; GLUTAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; MISOPROSTOL; PROPANTHELINE BROMIDE; PROSTAGLANDIN E2; RETINOIC ACID; SUCRALFATE; TETRACHLORODECAOXIDE; TOCOPHEROL;

CHRONOTHERAPY; CLINICAL PRACTICE; CRYOTHERAPY; DRUG ANTAGONISM; HUMAN; MOUTH HYGIENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; STOMATITIS;

ANTINEOPLASTIC AGENTS; CRYOTHERAPY; FLUOROURACIL; HUMANS; MOUTH MUCOSA; ORAL HYGIENE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; STOMATITIS;

EID: 0033755374     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200017040-00002     Document Type: Review

References (64)

1. Evaluating cost-effectiveness in outpatient management of medical complications in cancer patients
2. Oral complications in patients receiving treatment for malignancies other than the head and neck
3. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy
4. Studies on the prevention of 5-fluorouracil-induced oral mucositis
5. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients
6. Comparison of methods to determine the prevalence and nature of oral mucositis
7. Risk factors associated with mucositis in cancer patients receiving 5-FU
8. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity
9. An animal model for mucositis induced by cancer chemotherapy
10. Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis
11. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-florouracil-induced stomatitis
12. Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer
13. Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis
14. Inhibition of 5-fluorouracil-cisplatin-induced stomatitis by oral cryotherapy: Use of an ice-bar containing fibrinolysin and deoxyribonuclease combine (Elase)
15. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil related stomatitis
16. Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia
17. Propantheline prevention of mucositis from etoposide
18. High-dose methotrexate: A critical re-appraisal
19. Methotrexate-induced oral mucositis and salivary methotrexate concentrations
20. The modifying effect of beta-carotene on radiation and chemotherapy-induced oral mucositis
21. 2 for prophylaxis of oral mucositis following BMT
22. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial
23. Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis
24. Effect of topical oral G-CSF on oral mucositis: A randomized placebo-controlled trial
25. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy
26. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation
27. 5-Flourouracil and folinic acid-induced mucositis: No effect of oral glutamine supplementation
28. Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: A randomized double-blind study
29. The use of tretinoin as oral mucositis prophylaxis in bone marrow transplantation patients: A preliminary study
30. Differential effects of GMCSF in children with severe congenital neutropenia
31. Prevention and treatment of oral mucositis following cancer chemotherapy
32. Human GM-CSF is a growth factor active on a variety of cell types of non-hematopoietic origin
33. Interleukin-1 increases thymidine labelling index of normal tissue of mice but not the tumor
34. Alteration in the frequency, severity and duration of chemotherapy-induced mucosits in hamsters by interleukin-11
35. Inhibitors of mammalian G1 cyclin-dependent kinases
36. New frontiers in the management of chemotherapy-induced mucositis
37. Keratinocyte growth factor: A unique player in epithelial repair processes
38. Pre-clinical and early clinical development of keratinocyte growth-factor
39. Control of oral mucositis and candidiasis in marrow transplantation: A prospective, double-blind trial of chlorhexidine digluconate oral rinse
40. Chlorhexidine prophylaxis for chemotherapy and radiotherapy-induced stomatitis: A randomized double-blind trial
41. Effects of chlorhexidine during immunosuppressive chemotherapy: A prelimininary report
42. Effect of acyclovir on radiation and chemotherapy-induced mouth lesions
43. Acyclovir prophylaxis and fever during remission-induction therapy of patients with acute mycloid leukemia: A randomized, double-blind, placebo-controlled trial
44. Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy
45. Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis
46. Oropharyngeal mucositis complicating bone marrow transplantation: Prognostic factors and the effect of chlorhexidine mouth rinse
47. Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia
48. Randomized clinical trial of chlorbexidine versus placebo for prevention of oral mucosiris in patients receiving chemotherapy
49. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomized controlled trial comparing two protocols of dental care
50. A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation
51. Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: A prospective, randomized trial
52. A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis
53. Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy
54. Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy: A randomized, double-blind cross-over study
55. Efficacy of oral sucralfate suspention in prevention and treatment of chemotherapy-induced mucositis
56. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy
57. A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucosits
58. Vitamin E in the treatment of chemotherapy-induced mucositis
59. Treatment of mucositis with vitamine E prior to administration of myelosuppressive chemotherapy
60. The role of surveillance cultures in patients likely to develop chemotherapy-induced mucositis
61. Treatment for irradiation-induced mucositis
62. The impact of a systematic oral care protocol on stomatitis after chemotherap
63. Local antimicrobial therapy of oral mucositis in pediatric patients undergoing bone marrow transplantation
64. Oral complications